Full Program
RE(ACT) CONGRESS 2020:
WEDNESDAY, MARCH 11th
Session A, 14 to 17, “Session A: Methodologies to assess the effect of diagnostics and therapies in RD patients (workshop)”
POSTER SESSION A 17 to 18
Public Opening Ceremony 18 to 20
THURSDAY, MARCH 12th
Session B, 9 to 12, “Diagnostic, WGS, artificial intelligence, new technologies”
- Mark Caulfield, UK
- Tudor Groza, AUS
- Aravinda Chakravarti, USA – tbc
- Emmanouil Dermitzakis, CH – tbc
- Yaron Gurovich, USA – tbc
- Julian Isla Gomez, ES – tbc
LUNCH & POSTER SESSION B & C 12 to 13:30
Session C, 13:30 to 17, “Advanced therapies: gene editing, cell therapy“
- Alessandro Aiuti, IT
- Hans-Dieter Volk, DE
- Frank Baas, NL – tbc
- Hildegard Büning, DE – tbc
- Nathalie Cartier-Lacave, FR – tbc
FRIDAY, MARCH 13th
Session D, 9 to 12, “Molecular etiology of RD, innovative clinical trials, precision medicine”
- PJ Brooks, USA
- Terence Beghyn, FR
- Jean-François Deleuze, FR – tbc
- Kristina Larsson, NL – tbc
- Gisou van der Goot, CH – tbc
LUNCH & POSTER SESSION C & E 12 to 13:30
Session E, 13:30 to 17, “Access to diagnostic and drugs for all”
- Mengchun Gong, CN – tbc
- Benjamin Djoudalbaye, ET – tbc
- William Gahl, USA – tbc
- Susanne Weissbaecker, USA – tbc
- Durhane Wong-Rieger, CAN – tbc
SATURDAY, MARCH 14th
Session F, 9 to 12, “Patient engagement in drug development and clinical trial”
- Dimitrios Athanasiou, GR
- Nicola Bedlington, BE
Program updated July 18, 2019
